Skip to main content

Table 3 Treatment-related toxicity: NCI CTCAE v4.0 (N=38)

From: French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia

Adverse events (grade ≥3) Number of patients (%)
Febrile neutropenia 30 (79%)
Hepatic dysfunction 9 (24%)
Diarrhea 8 (21%)
Vomiting 7 (18%)
Hypokalemia 7 (18%)
Bacterial sepsis 6 (16%)
Mucositis 4 (10.5%)
Headache 4 (10.5%)
Multi-organ failure 4 (10.5%)
Lung infection 3 (8%)